Idelalisib 150mg Tablets

Idelalisib 150mg is a PI3K-delta inhibitor used in selected previously treated B-cell blood cancers, including chronic lymphocytic leukaemia treatment settings. It targets a pathway involved in malignant-cell survival.
Swallow the tablets whole at the scheduled times, with or without food. Infection-prevention treatment and blood-test appointments are part of the regimen rather than optional additions.
Idelalisib blocks PI3K-delta signalling in B cells, reducing signals that promote cancer-cell survival and movement into protective tissue environments.
Diarrhoea, nausea, fever, rash and fatigue can occur. Severe colitis, liver injury, lung inflammation and serious infections are important risks.
Liver tests and blood counts need close follow-up. Persistent cough, severe diarrhoea, fever or new abdominal pain requires prompt assessment. PJP prevention and CMV monitoring may be included.
Can suppress abnormal B-cell growth and improve control of disease that has returned after earlier treatment.
The risk of Pneumocystis infection may persist after idelalisib stops, so prevention can extend into recovery.
No. Immune-mediated colitis can occur after months of treatment and needs a different assessment.
Liver inflammation can appear before jaundice or abdominal symptoms develop.
A persistent cough or breathlessness needs assessment because infection and drug-related pneumonitis can have similar symptoms.
PI3K-delta: an enzyme involved in B-cell signalling. Colitis: inflammation of the colon. PJP: an opportunistic pneumonia caused by Pneumocystis. CMV: cytomegalovirus.; AR: Idelalisib 150mg أقراص; FR: Idelalisib 150mg comprimés; PT: Idelalisib 150mg comprimidos; ES: Idelalisib 150mg comprimidos; RU: Idelalisib 150mg таблетки; ID: Idelalisib 150mg tablet; VI: Idelalisib 150mg viên nén; MS: Idelalisib 150mg tablet; TL: Idelalisib 150mg mga tableta; ZH-SG: Idelalisib 150mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Idelalisib 150mg Tablets under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Idelalisib 150mg Tablets